Physician profile
Anthony Mac
NPI 1982379301
$5,295.86
in general payments reported to CMS, 2019-2025
15 companies · $755 in 2025
The $755 reported for 2025 was more than what 81% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $638 · 2023: $2,794 · 2024: $913 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,424 · Travel and Lodging: $1,019 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,424.08 |
| Travel and Lodging | $1,019.19 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,546.91 | 2022-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb Americas INC. | $1,457.04 | 2022-2025 | Miebo, Xiidra, Infuse |
| Dompe US, INC. | $447.59 | 2023-2025 | Oxervate |
| Abbvie INC. | $329.90 | 2022-2024 | |
| Oyster Point Pharma, INC. | $240.27 | 2023-2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $232.37 | 2023 | |
| Glaukos Corporation | $225.02 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
| Tarsus Pharmaceuticals, INC. | $163.01 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $152.38 | 2024 | Vevye |
| Novartis Pharmaceuticals Corporation | $135.81 | 2022 | |
| Horizon Therapeutics Plc | $124.99 | 2022 | |
| Allergan, INC. | $105.27 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $91.65 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.35 | 2023 | Cequa |
| Coopervision INC. | $19.30 | 2023 | Misight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.